Cargando…
Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma
Carbonyl reductase 1 (CBR1) is an enzyme that catalyzes the reduction of numerous compounds by using NADPH-dependent oxidoreductase activity. Decreased expression of CBR1 is associated with disease progression and an unfavorable outcome in several types of malignancies. The purpose of the current st...
Autores principales: | Yamanouchi, Ryota, Harada, Koji, Ferdous, Tarannum, Ueyama, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795658/ https://www.ncbi.nlm.nih.gov/pubmed/29456845 http://dx.doi.org/10.3892/mco.2018.1548 |
Ejemplares similares
-
Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
por: Harada, Koji, et al.
Publicado: (2017) -
Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
por: Itashiki, Yasutaka, et al.
Publicado: (2021) -
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
por: Harada, Koji, et al.
Publicado: (2017) -
PD-L1 expression in malignant salivary gland tumors
por: Harada, Koji, et al.
Publicado: (2018) -
Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2
por: Harada, Koji, et al.
Publicado: (2017)